TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29439718

Group type: EXPERIMENTAL
Intervention: SF-12v2® health survey
Number of subjects: 1587
Study: 28272343

Group type: EXPERIMENTAL
Intervention: Mobile Food Record (mFR) application
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: BMI ≥ 25
Number of subjects: 285
Study: 25641635

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 40,000 IU
Number of subjects: 69

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 69
Study: 23774797

Group type: EXPERIMENTAL
Intervention: LDA 100 mg (regimen A)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: LDA/clopidogrel (regimen AC)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg (regimen C)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: LDA with rabeprazole 10 mg (regimen AC)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Non-LDA subjects (control group in study 1)
Number of subjects: 215
Study: 20853136

Group type: EXPERIMENTAL
Intervention: Multivessel PCI (MV PCI)
Number of subjects: 31224

Group type: COMPARATOR
Intervention: Culprit only revascularization (COR)
Number of subjects: 31224
Study: 18777556

Group type: EXPERIMENTAL
Intervention: 0.2 mmol/kg of Gd-DTPA
Number of subjects: 12

Group type: COMPARATOR
Intervention: 0.1 mmol/kg of Gd-DTPA
Number of subjects: 12
Study: 16571279

Group type: EXPERIMENTAL
Intervention: Taizhi'an capsule (TZA) 0.9 g 3 times a day + Simvastatin (Sim) 10 mg at bedtime
Number of subjects: 80

Group type: COMPARATOR
Intervention: Simvastatin (Sim) 20 mg at bedtime
Number of subjects: 80
Study: 14570719

Group type: EXPERIMENTAL
Intervention: AZD3582 750 mg twice daily
Number of subjects: 31

Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 10889426

Group type: EXPERIMENTAL
Intervention: Optic capture technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-capture technique
Number of subjects: 40
Study: 7750187

Group type: EXPERIMENTAL
Intervention: Oral conjugated oestrogens (OCE, 0.625 mg) + Medroxyprogesterone acetate (MPA, 5 mg)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Transdermal oestradiol (TE, 50 micrograms) + Medroxyprogesterone acetate (MPA, 5 mg)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 43
Study: 2212918

Group type: EXPERIMENTAL
Intervention: Metronidazole 1 g daily for 7 days
Number of subjects: 171

Group type: COMPARATOR
Intervention: Tinidazole 2 g single dose
Number of subjects: 171
Study: 495848

Group type: EXPERIMENTAL
Intervention: Perioperative cephaloridine
Number of subjects: 107

Group type: COMPARATOR
Intervention: No cephaloridine
Number of subjects: 107
Study: 31769240

Group type: EXPERIMENTAL
Intervention: Insulin Degludec/Insulin Aspart (IDegAsp)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Basal Insulin
Number of subjects: 59
Study: 31417681

Group type: EXPERIMENTAL
Intervention: Pelmeg (Test)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Neulasta (Reference)
Number of subjects: 96
Study: 27756182

Group type: EXPERIMENTAL
Intervention: Theaflavin (50 or 100 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Catechin (400 mg/ml)
Number of subjects: 30
Study: 25932526

Group type: EXPERIMENTAL
Intervention: Electromagnetic (EM) guidance
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fluoroscopy
Number of subjects: 18
Study: 22788780

Group type: EXPERIMENTAL
Intervention: MMT CARE intervention
Number of subjects: 179

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 179
Study: 21507997

Group type: EXPERIMENTAL
Intervention: Parenting group curriculum program targeting young children's disruptive behaviors
Number of subjects: 39
Study: 18489576

Group type: EXPERIMENTAL
Intervention: Chlorhexidine + Fluoride varnish (Group 3)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Chlorhexidine varnish (Group 1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fluoride varnish (Group 2)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (Group 4)
Number of subjects: 80
Study: 16638862

Group type: EXPERIMENTAL
Intervention: High-dose IL-2
Number of subjects: 64

Group type: COMPARATOR
Intervention: Low-dose IL-2
Number of subjects: 64

Group type: COMPARATOR
Intervention: Concurrent high-dose IL-2
Number of subjects: 64

Group type: COMPARATOR
Intervention: Recombinant vaccinia and fowlpox vaccines
Number of subjects: 64

Group type: COMPARATOR
Intervention: Overall treatment with IL-2
Number of subjects: 64
Study: 12939169

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 1240

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1240
Study: 11139091

Group type: EXPERIMENTAL
Intervention: Revascularization (surgery or angioplasty)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 0
Study: 9414363

Group type: EXPERIMENTAL
Intervention: Left-handed users using their non-preferred hand
Number of subjects: 0

Group type: COMPARATOR
Intervention: Right-handed users using their preferred hand
Number of subjects: 0
Study: 8508692

Group type: EXPERIMENTAL
Intervention: 750 mg oral ciprofloxacin administered 1, 2 or 3 hours before anesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: 80 mg gentamicin plus 500 mg metronidazole administered intravenously
Number of subjects: 100
Study: 2433195

Group type: EXPERIMENTAL
Intervention: Trisequens (Novo)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sequentially Dienestrol and Chlormadinon (Polfa)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No hormone therapy (control group)
Number of subjects: 120
Study: 29169011

Group type: EXPERIMENTAL
Intervention: Hot yoga
Number of subjects: 14

Group type: COMPARATOR
Intervention: Thermo-neutral yoga
Number of subjects: 14
Study: 26792822

Group type: EXPERIMENTAL
Intervention: Model‐based iterative reconstruction (MBIR)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adaptive statistical iterative reconstruction (ASIR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Filtered back projection (FBP)
Number of subjects: 60
Study: 25502128

Group type: EXPERIMENTAL
Intervention: Cost-aware physicians (saw the cost of tests)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Cost-unaware physicians (did not see the cost of tests)
Number of subjects: 38
Study: 22285278

Group type: EXPERIMENTAL
Intervention: SQ-standardized grass allergy immunotherapy tablet (Grazax)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study: 20920198

Group type: EXPERIMENTAL
Intervention: Health Utilities Index Mark 3 (HUI3)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Predicted associations
Number of subjects: 213
Study: 18712620

Group type: EXPERIMENTAL
Intervention: Sustained release (SR) tablets of dextromethorphan hydrobromide
Number of subjects: 6

Group type: COMPARATOR
Intervention: Immediate release tablets of dextromethorphan hydrobromide
Number of subjects: 6
Study: 15968890

Group type: EXPERIMENTAL
Intervention: CO2 treatment for 18 days
Number of subjects: 2

Group type: COMPARATOR
Intervention: Air for 9 days + CO2 for 9 days (control group)
Number of subjects: 2
Study: 14629852

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan exercise program (12 weeks, 3 times per week)
Number of subjects: 76
Study: 10474465

Group type: EXPERIMENTAL
Intervention: Microneurovascular transfer
Number of subjects: 30

Group type: COMPARATOR
Intervention: Temporalis tendon transfer
Number of subjects: 30
Study: 8538345

Group type: EXPERIMENTAL
Intervention: Laser angioplasty
Number of subjects: 308

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 308
Study: 1351600

Group type: EXPERIMENTAL
Intervention: Traditional Chinese herbal therapy (TCHT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo herbs
Number of subjects: 40
Study: 3880780

Group type: EXPERIMENTAL
Intervention: Terodiline
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Meladrazine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combination of terodiline and meladrazine
Number of subjects: 25
Study: 31790452

Group type: EXPERIMENTAL
Intervention: CPP-ACPF + PBM
Number of subjects: 80

Group type: COMPARATOR
Intervention: PLACEBO
Number of subjects: 80

Group type: COMPARATOR
Intervention: CPP-ACPF
Number of subjects: 80

Group type: COMPARATOR
Intervention: PBM
Number of subjects: 80
Study: 29424447

Group type: EXPERIMENTAL
Intervention: Behavioural intervention programme consisting of 8 sessions, one per week, each lasting 90 minutes, run by a psychologist trained in behaviour analysis.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 120
Study: 30634203

Group type: EXPERIMENTAL
Intervention: Shenkang Injection (SI)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Rehydration therapy (normal saline)
Number of subjects: 206

Group type: COMPARATOR
Intervention: 5% glucose injection (control)
Number of subjects: 206
Study: 23996496

Group type: EXPERIMENTAL
Intervention: Packed red blood cell (PRBC) transfusion
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low baseline levels of BDNF, sVCAM‐1, PDGF‐AA, t‐PAI‐1, and sICAM‐1
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 80
Study: 22704950

Group type: EXPERIMENTAL
Intervention: LA+RT- (Lymphadenectomy + Radiotherapy)
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: RT (Radiotherapy)
Number of subjects: 742

Group type: COMPARATOR
Intervention: LA-RT- (No Lymphadenectomy nor Radiotherapy)
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: LA-RT+ (Lymphadenectomy without Radiotherapy)
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Both LA and RT
Number of subjects: 742
Study: 20158295

Group type: EXPERIMENTAL
Intervention: Negative affect cue (speech preparation task)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: External smoking cue (pictures of cigarettes)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Both types of cues
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Impulsivity measures
Number of subjects: 175
Study: 18677177

Group type: EXPERIMENTAL
Intervention: Intensified preventive care involving a practice nurse, peer health educator, GP, and GP assistant
Number of subjects: 275

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 275
Study: 15952024

Group type: COMPARATOR
Intervention: Control temperature (34.2 ± 0.3 degrees C)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cold temperature (31.3 ± 0.5 degrees C)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Warm temperature (37.1 ± 0.2 degrees C)
Number of subjects: 20
Study: 12182909

Group type: EXPERIMENTAL
Intervention: front-loaded rt-PA (up to 100 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TNK-tPA (single bolus up to 50 mg)
Number of subjects: 30
Study: 10469772

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.25 mg/kg on days 1-7, 0.12 mg/kg on days 8-14, 0.05 mg/kg on days 15-21, 0.02 mg/kg on days 21-28)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 179
Study: 8733214

Group type: EXPERIMENTAL
Intervention: Paired Associate Learning Test (PALT)
Number of subjects: 2584
Study: 1725549

Group type: EXPERIMENTAL
Intervention: Calcium blockers (diltiazem)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium antagonists (dihydropiridines)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium blockers and ACE inhibitors
Number of subjects: 0
Study: 6218948

Group type: EXPERIMENTAL
Intervention: 150 mg levamisole once weekly
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 350 mg daily doses of levamisole for 3 consecutive days weekly
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31448876

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training plus postural or positional inversion exercises
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pelvic floor muscle training (control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (baseline comparison)
Number of subjects: 40
Study: 31453722

Group type: EXPERIMENTAL
Intervention: Prehospital vulnerability (VES ≥ 3)
Number of subjects: 301
Study: 26940357

Group type: EXPERIMENTAL
Intervention: Plant stanol ester enriched margarines (3.0g/d plant stanols)
Number of subjects: 13
Study: 26577415

Group type: COMPARATOR
Intervention: Maternal diabetes exposure (either pre-pregnancy diabetes or gestational diabetes)
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: Non-exposure to maternal diabetes
Number of subjects: 632
Study: 25076474

Group type: EXPERIMENTAL
Intervention: 0.45% ketorolac tromethamine + carboxymethylcellulose
Number of subjects: 50

Group type: COMPARATOR
Intervention: Artificial tears alone
Number of subjects: 50
Study: 22385563

Group type: EXPERIMENTAL
Intervention: Amygdala retraining along with standard care
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 44
Study: 20565997

Group type: EXPERIMENTAL
Intervention: High energy turnover (HET)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Low energy turnover (LET)
Number of subjects: 13
Study: 17906163

Group type: EXPERIMENTAL
Intervention: Tadalafil (5 mg/d) with doxazosin (1, 2, and 4 mg/d)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Tadalafil (5 mg/d) with tamsulosin (0.4 mg/d)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo with doxazosin (4 mg/d)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo with tamsulosin (0.4 mg/d)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Tadalafil alone
Number of subjects: 84

Group type: COMPARATOR
Intervention: Doxazosin (4 mg/d) with placebo
Number of subjects: 84
Study: 16140675

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment 0.03%
Number of subjects: 317

Group type: COMPARATOR
Intervention: Vehicle ointment
Number of subjects: 317
Study: 12186264

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0
Study: 9451062

Group type: EXPERIMENTAL
Intervention: 7.2% saline solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: gelatin
Number of subjects: 20
Study: 7658056

Group type: EXPERIMENTAL
Intervention: Aerosolized pentamidine, 300 mg every month
Number of subjects: 196

Group type: COMPARATOR
Intervention: Dapsone, 50 mg/day
Number of subjects: 196
Study: 2684251

Group type: EXPERIMENTAL
Intervention: Extradural clonidine (EC) 2 micrograms kg‐1 in isotonic saline solution 15 micrograms ml‐1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Extradural saline (ES) equivalent volume of plain isotonic saline solution
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Extradural clonidine (EC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Extradural saline (ES)
Number of subjects: 20
Study: 29654849

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Metformin + Rosiglitazone
Number of subjects: 371

Group type: COMPARATOR
Intervention: Rosiglitazone
Number of subjects: 371

Group type: COMPARATOR
Intervention: Insulin regimens (short or long-acting)
Number of subjects: 371

Group type: COMPARATOR
Intervention: HbA1c
Number of subjects: 371

Group type: COMPARATOR
Intervention: Overall BTMs
Number of subjects: 371
Study: 28830529

Group type: COMPARATOR
Intervention: Chlorhexidine
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Classical MB-PDT
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Mouthwash MB-PDT
Number of subjects: 52

Group type: COMPARATOR
Intervention: Mechanical cleaning with filtered water
Number of subjects: 52
Study: 25381858

Group type: EXPERIMENTAL
Intervention: LPS + HDM
Number of subjects: 32

Group type: COMPARATOR
Intervention: HDM
Number of subjects: 32
Study: 23426461

Group type: EXPERIMENTAL
Intervention: teduglutide (0.5 mg/kg/d)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: teduglutide (0.10 mg/kg/d)
Number of subjects: 83

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 83
Study: 22015086

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 63
Study: 18545055

Group type: EXPERIMENTAL
Intervention: Escitalopram (10-20 mg/day)
Number of subjects: 564

Group type: COMPARATOR
Intervention: Duloxetine (60 mg/day)
Number of subjects: 564
Study: 16298087

Group type: EXPERIMENTAL
Intervention: Gabapentin 1000mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Gabapentin 2000mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Gabapentin 0mg (Control)
Number of subjects: 17
Study: 12882844

Group type: EXPERIMENTAL
Intervention: Specialist nurse-led clinics for hypertension and hyperlipidemia
Number of subjects: 1407

Group type: EXPERIMENTAL
Intervention: Specialist nurse-led clinic for hyperlipidemia
Number of subjects: 1407

Group type: EXPERIMENTAL
Intervention: Specialist nurse-led clinic for hypertension
Number of subjects: 1407

Group type: EXPERIMENTAL
Intervention: Specialist nurse-led clinics (enrolled to either or both clinics)
Number of subjects: 1407

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1407
Study: 10892359

Group type: EXPERIMENTAL
Intervention: Invasive surgical treatments for acute myocardial infarction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insurance subpopulations
Number of subjects: 0
Study: 9001926

Group type: EXPERIMENTAL
Intervention: Metered Dose Inhaler (MDI) - nedocromil sodium 4 mg + salbutamol 0.2 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nebulizer Solution - nedocromil sodium 10 mg + salbutamol 1.5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metered Dose Inhaler (MDI)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nebulizer Solution
Number of subjects: 12
Study: 1453242

Group type: EXPERIMENTAL
Intervention: Influenza vaccination program
Number of subjects: 500
Study: 6424240

Group type: EXPERIMENTAL
Intervention: Daily topical applications of povidone‐iodine
Number of subjects: 179

Group type: COMPARATOR
Intervention: Dry dressing changes
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: CVCs in place for 0 to 7 days
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: CVCs in place for 8 to 30 days
Number of subjects: 179
Study: 29933269

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation training (6 hours)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 50
Study: 29273946

Group type: EXPERIMENTAL
Intervention: Project Bridge (PB), an intensive case‐management intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU), standard referral to treatment
Number of subjects: 0
Study: 26221051

Group type: EXPERIMENTAL
Intervention: Theta Burst Transcranial Magnetic Stimulation (TB‐rTMS)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo treatment (sham)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: TB‐rTMS
Number of subjects: 71
Study: 24316509

Group type: EXPERIMENTAL
Intervention: Yamamoto's acupuncture method (5 sessions)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham acupuncture (5 non-penetrating sessions)
Number of subjects: 80
Study: 23185756

Group type: EXPERIMENTAL
Intervention: Chinese herbal enema therapy (CHET), once daily for 2 weeks as one therapeutic course
Number of subjects: 84

Group type: COMPARATOR
Intervention: Basic treatment (control group)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Chinese herbal enema therapy (CHET)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Chinese herbal enema therapy (CHET) and basic treatment
Number of subjects: 84
Study: 20397286

Group type: EXPERIMENTAL
Intervention: Bupropion XL 300 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 17907089

Group type: EXPERIMENTAL
Intervention: Vessel sealing
Number of subjects: 150

Group type: COMPARATOR
Intervention: Suture ligation
Number of subjects: 150
Study: 16335686

Group type: EXPERIMENTAL
Intervention: Obese women with diabetes type 2 (group A)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Insulin treatment (subgroup AII)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Sulfonylurea treatment (subgroup AI)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Obese women without additional disease (group B)
Number of subjects: 46
Study: 11866674

Group type: EXPERIMENTAL
Intervention: Triptans (specifically sumatriptan)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality of Life (QOL) measures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparative pharmacoeconomic analyses of triptans
Number of subjects: 0
Study: 10890232

Group type: EXPERIMENTAL
Intervention: Transposition of the greater omentum into the thorax
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunoglobulins
Number of subjects: 0
Study: 7787918

Group type: EXPERIMENTAL
Intervention: Music-listening group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonmusic (headphones only) group
Number of subjects: 20
Study: 2403227

Group type: EXPERIMENTAL
Intervention: 0.1 mL influenza vaccine
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 0.05 mL influenza vaccine
Number of subjects: 29

Group type: COMPARATOR
Intervention: 0.5 mL influenza vaccine
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 0.1 mL and 0.05 mL influenza vaccine
Number of subjects: 29
Study: 630187

Group type: EXPERIMENTAL
Intervention: ioglycamide (Biligram) at 3 mg/kg/min for one hour
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: ioglycamide (Biligram) at 4 mg/kg/min for one hour
Number of subjects: 80

Group type: COMPARATOR
Intervention: ioglycamide (Biligram) at 2 mg/kg/min drip infusion
Number of subjects: 80

Group type: COMPARATOR
Intervention: ioglycamide (Biligram) by 10 minute slow hand injection
Number of subjects: 80
Study: 31994819

Group type: COMPARATOR
Intervention: Conventional medical therapy (control group)
Number of subjects: 458
Study: 31596419

Group type: EXPERIMENTAL
Intervention: Scenarios with debriefing (experimental group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Scenarios without debriefing (control group)
Number of subjects: 120
Study: 28632975

Group type: EXPERIMENTAL
Intervention: Reminders, encouragement, and educational messages delivered by mobile phone for 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group (no messages)
Number of subjects: 0
Study: 26690683

Group type: EXPERIMENTAL
Intervention: 6% HES 130/0.4
Number of subjects: 826

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 826